Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-001651
Filing Date
2017-01-05
Accepted
2017-01-05 08:51:34
Documents
1
Period of Report
2017-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4108
  Complete submission text file 0001209191-17-001651.txt   5473
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address
Thackray Helen M. (Reporting) CIK: 0001589725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 17509065